TSNLF (Tristel) Loans Receivable: $0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSNLF Tristel PLC TSNLF
94 GF Score
Price $6.00
GF Value $6.10
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Tristel Loans Receivable?

Tristel TSNLF +13.64% 94 Loans Receivable is $0.00 Mil as of Dec. 2025. GuruFocus rates TSNLF with a GF Score™ of 94/100 and a GF Value™ of $6.10 (Fairly Valued). The stock has 1 warning sign investors should review.

Tristel's Loans Receivable for the quarter that ended in Dec. 2025 was $0.00 Mil.

Tristel Loans Receivable Historical Data

* Premium members only.

The historical data trend for Tristel's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tristel Loans Receivable Chart

Tristel Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Tristel Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSNLF
94GF Score
Tristel PLC TSNLF
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tristel Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of $0.00 Mil mean?
Tristel (TSNLF) has a Loans Receivable of $0.00 Mil as of Dec. 2025. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Tristel and its competitors.
Is Tristel's Loans Receivable too high?
Tristel's current Loans Receivable is $0.00 Mil. Overall, Tristel has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tristel's Loans Receivable compare to ISRG and BDX?
Tristel's Loans Receivable of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Medical Devices & Instruments company?
A good Loans Receivable depends on the Medical Devices & Instruments industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Tristel and its competitors. Tristel's current Loans Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tristel stock overvalued right now?
Based on GuruFocus' analysis, Tristel (TSNLF) is currently considered Fairly Valued. The stock's GF Value™ is $6.10, compared to a current price of $6.00 — trading 1.6% below its estimated fair value. The current Loans Receivable is $0.00 Mil. Tristel's overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Tristel (TSNLF), the current Loans Receivable is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tristel (TSNLF) Overvalued in 2026?

Based on GuruFocus' analysis, Tristel stock appears to be undervalued. The current stock price of $6.00 is trading 1.6% below its estimated GF Value™ of $6.10. GuruFocus considers Tristel to be Fairly Valued.

Key valuation signals for TSNLF:

  • Loans Receivable: $0.00 Mil
  • GF Value™: $6.10 vs. price of $6.00 (1.6% below fair value)
  • GF Score™: 94/100 with 1 warning sign

No single metric tells the full story. See the TSNLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tristel Business Description

Other Exchanges TSTL:UKR1V:Germany
Address Fordham Road, Unit 1B, Lynx Business Park, Newmarket, Snailwell, Cambridgeshire, GBR, CB8 7NY
Tristel PLC's business is the sale to hospitals of its proprietary chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand and for the sporicidal disinfection of environmental surfaces under the Cache brand. Its operating segments include hospital medical device decontamination products used predominantly for infection control in hospitals; the manufacture and sale of hospital environmental surface disinfection products; and pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare. The company generates the majority of its revenue from hospital medical device decontamination and operates geographically in the UK and overseas markets.
94GF Score

Get the complete analysis for TSNLF

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.00
Price
$6.10
GF Value